Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lectin-like domain of TNF-α is a specific region within the TNF-α protein (residues Cys101-Glu116 in humans) that binds to certain oligosaccharides. This domain is spatially distinct from the receptor-binding sites of TNF-α and exerts unique biological effects, including the activation of epithelial sodium channels (ENaC) and modulation of inflammation. Synthetic peptides mimicking this domain, such as solnatide/TIP peptide, are being developed as therapeutics for acute lung injury and other inflammatory conditions. The mechanism involves binding to glycosylated membrane components of ENaC, followed by uptake into lipid rafts and direct activation of the channel, leading to increased sodium and fluid clearance.
Binds to glycosylated membrane components, taken up into lipid rafts, and directly interacts with ENaC's α subunit, leading to increased ENaC membrane abundance and activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Necrosis Factor Alpha Lectin-Like Domain (TNF-α Lectin-Like Domain).